Fact CheckerSign in

NCT07326514Not yet recruiting

Electronic Real-Time Heart Team Decision-making vs. Usual Care in Patients With Triple-Vessel Coronary Artery Disease and Diabetes Mellitus

Source: ClinicalTrials.gov · Last updated 8 Jan 2026

Brief summary (registry, in English)

This is a multi-center randomized controlled trial involving patients with 3-vessel coronary artery disease and diabetes mellitus. Enrolled patients will be dividing into real-time heart team decision-making group (intervention group) and usual care group (control group). The intervention group will conduct a real-time online multidisciplinary heart team discussion and decision-making during coronary angiography. The control group will conduct an usual care decision-making.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
1350 (estimated)
First submitted
28 Nov 2025
Start date
1 Jan 2026
Primary completion date
1 Jun 2028
Lead sponsor
China National Center for Cardiovascular Diseases
NCT number
NCT07326514

What you commit to

  • Study type: Interventional
  • Planned participants: 1350
  • From 1 Jan 2026 to the primary completion date, 1 Jun 2028
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Prior PCI or CABG;
  • Concurrent severe valvular heart disease, large vessel disease, or giant ventricular aneurysm requiring surgical intervention;
  • Concurrent atrial fibrillation or severe arrhythmia;

Other illness

  • Acute myocardial infarction with ECG and biomarker tests indicating acute phase;

Other

  • Other emergency admissions where elective revascularization is contraindicated;
  • Refusal or rejection of a specific treatment options (PCI or CABG);
  • Refusal to participate in the study.

Who the study is looking for

  • Age ≥ 18 years;
  • Diabetes mellitus;
  • Three-vessel coronary artery disease (≥70% stenosis in the left anterior descending artery, circumflex artery, and right coronary artery system);
  • Patients who required heart team discussion judging by the interventional cardiologist.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.